Northern Trust Corp Pharma Cyte Biotech, Inc. Transaction History
Northern Trust Corp
- $690 Billion
- Q4 2024
A detailed history of Northern Trust Corp transactions in Pharma Cyte Biotech, Inc. stock. As of the latest transaction made, Northern Trust Corp holds 19,208 shares of PMCB stock, worth $31,501. This represents 0.0% of its overall portfolio holdings.
Number of Shares
19,208
Previous 19,208
-0.0%
Holding current value
$31,501
Previous $36,000
19.44%
% of portfolio
0.0%
Previous 0.0%
Shares
9 transactions
Others Institutions Holding PMCB
# of Institutions
28Shares Held
706KCall Options Held
9.3KPut Options Held
4.6K-
Vanguard Group Inc Valley Forge, PA192KShares$315,5140.0% of portfolio
-
Geode Capital Management, LLC Boston, MA165KShares$270,1670.0% of portfolio
-
Ayrton Capital LLC Westport, CT92.1KShares$151,0227.31% of portfolio
-
Equitec Proprietary Markets, LLC82.7KShares$135,6720.07% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny49.3KShares$80,8520.0% of portfolio
About PharmaCyte Biotech, Inc.
- Ticker PMCB
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 20,750,100
- Market Cap $34M
- Description
- PharmaCyte Biotech, Inc., a biotechnology company, focuses on developing and commercializing cellular therapies for cancer, diabetes, and malignant ascites in the United States. Its cellular therapies are developed based on Cell-in-a-Box, a proprietary cellulose-based live cell encapsulation technology used as a platform to treat various types o...